Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets.
about
Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beside P53 and PTEN: Identific ...... ial novel therapeutic targets.
@en
Beside P53 and PTEN: Identific ...... ial novel therapeutic targets.
@nl
type
label
Beside P53 and PTEN: Identific ...... ial novel therapeutic targets.
@en
Beside P53 and PTEN: Identific ...... ial novel therapeutic targets.
@nl
prefLabel
Beside P53 and PTEN: Identific ...... ial novel therapeutic targets.
@en
Beside P53 and PTEN: Identific ...... ial novel therapeutic targets.
@nl
P2093
P2860
P356
P1433
P1476
Beside P53 and PTEN: Identific ...... ial novel therapeutic targets.
@en
P2093
Alexandre Harlé
Catherine Barlier
Céline Gavoilles
Elisa Cavazza
Jean-Louis Merlin
Julia Salleron
Pierre Filhine-Tresarrieu
Shuhui Chen
P2860
P304
P356
10.3892/OL.2016.5083
P577
2016-09-02T00:00:00Z